Axcella Health Inc 's

• AXLA's Stock Performance relative to its Competitors

Taysha Gene Therapies Inc Share Performance -8.93% Over The Past 5 Days

Taysha Gene Therapies Inc Profile Taysha Gene Therapies Inc operates under a business model focused on developing and commercializing innovative genetic therapies to treat and potentially cure patients with rare monogenic diseases. Utilizing cutting-edge technologies, the company aims to bring transformative treatments to market in order to improve the lives of individuals suffering from these rare genetic disorders. More about Taysha Gene Therapies Inc 's Market Share

4d Molecular Therapeutics Inc Share Performance +95.01% This Year

4d Molecular Therapeutics Inc Profile 4D Molecular Therapeutics Inc operates with a business model focused on developing innovative gene therapy products to address serious genetic diseases. The company utilizes its proprietary technology platform to design and optimize viral vectors for targeted gene delivery. With a strong commitment to research and development, 4D Molecular Therapeutics collaborates with partners in academia, industry, and patient organizations to advance transformative treatments for patients in need. More about 4d Molecular Therapeutics Inc 's Market Share

Exelixis Inc Share Performance +33.64% This Year

Exelixis Inc Profile Exelixis Inc's business model is focused on the discovery, development, and commercialization of innovative therapies for the treatment of cancer. More about Exelixis Inc 's Market Share

Tradeup Acquisition Corp Share Performance -60.76% One Year

Tradeup Acquisition Corp Profile Estrella Immunopharma Inc is a biotechnology company that focuses on developing innovative immunotherapies. They have a business model centered around researching, developing, and commercializing novel treatments for various diseases. Their approach includes leveraging the power of the immune system to target and eradicate diseases, with a particular emphasis on cancer. More about Tradeup Acquisition Corp's Market Share

Entera Bio Ltd Share Performance -12.86% 30 Days

Entera Bio Ltd Profile Entera Bio Ltd is a pharmaceutical company that focuses on the development and commercialization of orally delivered drugs for various diseases. They leverage their proprietary technology platform to enhance the absorption and delivery of these therapeutics, potentially offering increased patient convenience and treatment efficacy. More about Entera Bio Ltd 's Market Share

Sources: Axcella Health Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 26, 2026 7:43 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Axcella Health Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.